ABSTRACT: Objective To evaluate the efficacy and safety of nateglinide, a new antidiabetic agent, in the treatment of type 2 diabetes.
摘要：目的评价那格列奈治疗2型糖尿病的有效性和安全性。
Nateglinide is a novel non-sulfonylurea antidiabetic agent by stimulating insulin secretion. Its action occurs rapidly and sustains shortly.
那格列奈是一种新型的非磺酰脲类促胰岛素分泌的降糖新药，其起效快且作用时间较短。
Nateglinide is a novel non-sulfonylurea antidiabetic agent by stimulating insulin secretion. Its action occurs rapidly and sustains shortly.
那格列奈是一种新型的非磺酰脲类促胰岛素分泌的降糖新药，其起效快且作用时间较短。
应用推荐